



Shemesh et al. Cardiovascular Diabetology 2013, 12:161
http://www.cardiab.com/content/12/1/161ORIGINAL INVESTIGATION Open AccessCoronary calcium in patients with and without
diabetes: first manifestation of acute or chronic
coronary events is characterized by different
calcification patterns
Joseph Shemesh1,2†, Alexander Tenenbaum1,2,3†, Enrique Z Fisman2,3*, Nira Koren-Morag2 and Ehud Grossman1,2Abstract
Background: Coronary artery calcification (CAC) is closely related to coronary atherosclerosis. However, less is
known about the clinical significance of extensive CAC (ECAC) in regard to types of first coronary events (acute vs.
chronic). Diabetes mellitus (DM) represents a strong risk factor for CAD although its association with CAC is
controversial. Aiming to elucidate these controversies we investigated the long-term outcome of coronary artery
disease (CAD) in relation to degree of CAC in patients with and without DM from our annual cheek-up outpatient
clinic.
Methods: Coronary artery computed tomography (CT) was performed in 667 patients who were yearly evaluated
during a mean follow-up period of 6.3 ±3.4 year. The following 4 CAC categories were established: calcium absence;
total calcium score (TCS): 1–100 AU; TCS: 101–600 AU and ECAC: TCS above 600 AU. Acute event was defined as
first acute myocardial infarction (MI) or a new unstable angina. First chronic event was defined as a positive stress
test with a consequent elective percutaneous coronary intervention or coronary artery bypass grafting.
Results: 628 subjects (94%) were free from any cardiac events, 39 (6%) experienced first cardiac event: 18 of them
suffered acute and 21 chronic events. There were 67 patients with and 600 patients without DM: 78% of patients
with DM presented CAC vs. 50% of patients without DM (p < 0.001).The mean TCS was 17 times higher in the
chronic than in the acute events group: 914 vs. 55 AU, p < 0.001. In 95% of the patients with chronic events more
than one calcified vessel was found, compared to 67% of the patients with acute events and only 30% of those
without events (p < 0.001). Incidence of CAD events (all types pooled together) rose consequently from 2% in
subjects without CAC to 34% in subjects with ECAC (p < 0.001). However, among the 32 subjects with ECAC, 11
(34%) developed chronic event while none of them had acute event. In contrast, none of subjects with TCS =0 or
TCS 1–100 AU presented with chronic events. Subjects with TCS 101–600 AU presented 10 (9%) chronic and
5 (4.5%) acute events (p < 0.001).
Conclusions: Asymptomatic subjects with ECAC are not firstly manifested as acute coronary events but presented a
high level of chronic CAD-related events during the 6.3 ±3.4 year follow-up. In contrast, first acute CAD-related
events occurred mostly in subjects with mild and moderate CAC score.
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http://www.cardiab.com/content/12/1/161Coronary artery calcification (CAC) is a well established
surrogate marker of the total burden of coronary athero-
sclerosis [1-3]. Large prospective studies consistently
demonstrated that higher CAC scores are associated
with increased risk for coronary artery disease (CAD) re-
lated events [4,5] and that addition of CAC score to
traditional risk factors improves risk stratification [5,6].
Previously, we [7,8] and others [9] have suggested that
subjects with extensive CAC (ECAC) are at increased
risk of stable angina but not of acute coronary syn-
drome, compared to the those with the lower CAC
scores.Diabetes mellitus (DM) represents a strong risk
factor for CAD, albeit its association with CAC is con-
troversial. While a number of studies have found signifi-
cant relationship between high CAC and DM [10-13],
the Multi-Ethnic Study of Atherosclerosis (MESA) did
not confirm this association [9]. In an aim to elucidate
these controversies we sought to investigate the long-
term CAD outcome (stratified according to chronic or
acute events) in relation to degree of CAC in patients
with and without DM undergoing our annual cheek-up
outpatient clinic.Material and methods
Patient selection
Seven hundred and forty five consecutive subjects who
consented to perform a cardiac computed tomography
(CT) for coronary calcium evaluation were recruited
from our annual cheek-up clinic between January 2001
and January 2002. The inclusion criteria for screening
were men above 40 and women above 50 years free of
cardiovascular disease. Those who had at least one year
of follow-up were included in the present analysis. Seventy
six subjects who never returned to the annual check-up
were excluded and two others were excluded since an
acute MI was found in their files before the study entry.
The remaining 667 subjects comprised our study group.
All underwent CT at baseline visit and were then yearly
evaluated. The development of events was finally assessed
on February 2011. So, the follow-up period was until the
first diagnosis of event, death, last annual check –up, or
31 January 2011, providing a maximum follow-up of
10 years, mean 6.3 ±3.4 years.Events definition
Only first coronary events were analyzed. We defined
acute event as first acute MI or hospitalization for a new
unstable angina. Chronic event was defined as positive
stress test on the routine annual check-up, with or with-
out chest pain, with a consequent elective coronary
catheterization resulting in percutaneous coronary inter-
vention (PCI) or coronary artery bypass grafting (CABG).Follow-up
Events were recorded from the files of the annual check-
up program in our institute and were verified by the
available documentation. Data on mortality and cause of
death were available for all participants from the registry
of the Ministry of Internal Affairs. A written informed
consent was obtained from all patients and the entire
study protocol was approved by the Sheba Medical Center
Helsinki Committee.
Annual check-up
All subjects were clinically evaluated at baseline and
then annually, and a detailed medical history and stand-
ard physical examination were performed. The following
variables were recorded: age, height, weight, concomi-
tant diseases, smoking habits, and laboratory evaluation.
Estimated glomerular filtration rate (eGFR) was calculated
according to the Chronic Kidney Disease Epidemiology
Collaboration (CKD-EPI) equation [14].
Coronary CT
All CT scans were performed on a dual-detector spiral
CT without ECG gating and without contrast injection.
Scanning protocol and CAC measuring were done ac-
cording to a previously published protocol using the
modified Agatston method [15]. Total CAC score was
the sum of all the individual calcific lesions identified
within the area of the coronary arteries. The reproduci-
bility of calcification scoring by this method is high, with
an intra class correlation coefficient of 0.99 and of 0.94
for inter-observer agreement [16]. The following 4 CAC
categories were distinguished: absence of CAC; mild-
moderate CAC: 1–100 AU; high CAC: 101–600 AU and
very high ECAC score: above 600 AU, which corresponds
to the 95th percentile in our cohort.
A TCS > 0 was considered positive for the presence of
any CAC. The number of coronary vessels with CAC
was recorded for each subject and defined as having at
least one calcific lesion in one of the 4 regions: main left
artery, left anterior descending artery (LAD) and its
branches, left circumflex artery (LCX) and its branches
and right coronary artery (RCA) and its branches.
Assessment of cardiovascular risk factors
Height and weight were measured with participants
wearing light clothing without shoes. The body mass
index (BMI) was calculated as weight (Kg) divided by
the square of the height. Blood pressure (BP) was mea-
sured in the seated position after 3 minutes of rest.
Hypertension was defined when BP levels were twice
≥140 mm Hg for systolic BP and/or ≥90 mm Hg for dia-
stolic BP or a history of hypertension was reported or
when the subject was on antihypertensive medications.
Diabetes mellitus (DM) was defined when fasting plasma
Table 1 Baseline characteristics of the study population
Characteristics No event N = 628 Acute event N = 18 Chronic event N = 21 p value
Age 55 ± 7.2 57 ± 8.2 60 ± 7.7 0.007
Male gender 526 (84) 17 (94) 21 (100) 0.073
BMI (kg/m2) 27.0 ± 3.5 27.7 ± 4.0 26.2 ± 2.7 0.395
SBP (mmHg) 126 ± 17 124 ± 15 130 ±13 0.444
DBP (mmHg) 79 ± 9 78 ± 9 79 ± 6 0.906
Hypertension 163 (26) 5 (28) 12 (57) 0.007
Diabetes 60 (10) 3 (17) 4 (19) 0.232
Current smokers 106 (22) 4 (33) 5 (31) 0.454
Chronic renal failure 14 (2) 1 (6) 1 (5) 0.511
CAD family history 162 (26) 3 (18) 7 (35) 0.486
Hyperlipidemia 284 (47) 9 (50) 12 (60) 0.475
Urea (mg/dl) 33 ± 7.7 35 ± 7.7 32 ± 5.7 0.557
Creatinine (mg/dl) 1.07 ± 0.15 1.08 ± 0.17 1.13 ± 0.11 0.179
Glucose (mg/dl) 99 ± 23 96 ± 18 101 ± 21 0.761
Calcium (mg/dl) 9.6 ± 0.45 9.6 ± 0.46 9.6 ± 0.50 0.908
Phosphorus (mg/dl) 3.02±0.50 2.76 ± 0.27 3.0 ± 0.69 0.088
Triglyceride (mg/dl) 143 ± 79 156 ± 63 133 ± 58 0.671
Total cholesterol (mg/dl)
HDL-cholesterol (mg/dl) 45 ±12 40 ± 5 45 1 ± 3 0.243
LDL-cholesterol (mg/dl) 127 ± 29 127 ± 37 127 ± 26 0.999
Data are number (%) of patients or mean ± SD.
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(7.0 mmol/L), a history of DM was reported or when the
patient was on insulin or oral hypoglycemic medications.
Hypercholesterolemia was defined when measured total
cholesterol was > 250 mg/dl, or when the patient reported
medication with cholesterol lowering agents. Smoking
status was determined according to the questionnaire.
Statistical methods
Data were analyzed with IBM SPSS software version
21.0 and were presented as frequencies and percentages
for categorical variables and as mean and standard devi-
ation for continuous variables. Significance levels were
set at 0.05. The distributions of continuous variables in
the study were examined using the Kolmogorov-SmirnovTable 2 The CAC characteristics according to outcome during
Variable No event N = 628 Acute ev
TCS mean (SD) 93 ± 276 55 ± 62
TCS >0 311 (50) 13 (72)
CV > 1 187 (30) 12 (67)
No CV mean (SD) 1.02 ± 1.15 1.72 ± 1.2
TCS - Total calcium score (AU); CV - calcified vessel >1 - more than one calcified ma
including their branches; No CV – mean number of calcified major coronary vessels
For TCS >0 and CV > 1 data are number (%) of patients.non-parametric test. To demonstrate the differences be-
tween the event groups (no event, chronic event and acute
event), Chi-Square tests were analyzed for differences in
categorical baseline characteristics and incidence of events
between the groups. One-way ANOVA tests were per-
formed for continuous characteristic including TCS values,
following by analysis of covariance (ANCOVA) to adjust
for age as a potential covariate.
Results
The mean period of follow-up was 6.3 ±3.4 year. During
this period 628 subjects (94%) were free from any cardiac
events (Group I). Throughout follow up 39 (6%) of pa-
tients experienced a cardiac event: 18 of them suffered
acute events (13 acute MI and 5 unstable angina pectoris –follow-up
ent N = 18 Chronic event N = 21 p value
914 ± 660 <0.001
21 (100) <0.001
20 (95) <0.001
3 3.05 ± 0.74 <0.001
jor coronary vessel in one of the 4 regions: main left artery, LAD, LCX and RCA
.
Table 3 Incidence of acute and chronic events by TCS categories
Type of
event
TCS = 0 TCS 1–100 TCS 101–600 TCS > 600 p value
N = 315 N = 208 N = 112 N = 32 (age-adjusted)
All types 5 (2) 8 (4) 15 (13.5) 11 (34)
<0.001Acute 5 (2) 8 (4) 5 (4.5) 0
Chronic 0 0 10 (9) 11 (34)
Data are number (%) of patients.
TCS - Total calcium score (AU).
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mented (Group III). Eight patients died without having
any known prior cardiac event (non-cardiac death).
The baseline characteristics of the participants are
given in Table 1. Patients with events were older than
those without and those with chronic events were older
than those with acute. The frequency of hypertension
was twice higher among those with chronic than in
those with acute event and no events. All the other clin-
ical and laboratory parameters were not statistically dif-
ferent between study groups. There were 67 patients
with and 600 patients without diabetes in our study. It
should be pointed out that 78% of the patients with DM
had CAC (TCS above zero) vs. 50% of patients without
DM (p < 0.001).
The CAC characteristics of patients are given in Table 2.
Among subjects without events half had CAC (TCS > 0)
while all those with chronic and three quarter of the acute
events group had CAC. Equally, the mean CAC score was
10 times higher in the chronic events group than in thoseFigure 1 Incidence of acute and chronic events by TCS categories. TCwithout events (914 vs. 93 AU) and 17 times higher than
the mean TCS of the acute group (914 vs. 55 AU). Ninety
five percent of the patients with chronic events had more
than one calcified vessel compared to 67% of the patients
with acute events and only 30% of those without events
(p < 0.001).
The incidence of acute and chronic events by TCS cat-
egories is given in Table 3 and Figure 1. During follow-
up incidence of the CAD events (all types pooled to-
gether) rose consequently from 2% in subjects without
CAC to 34% in subjects with the highest CAC category
TCS > 600 AU (p < 0.001). However, different pattern in
the development of the first acute and chronic coronary
events in accordance with the CAC category was ob-
served. Among the 32 subjects with TCS > 600 AU, 11
(34%) developed chronic event while none of them had
acute event. In contrast, none of subjects with TCS = 0
or TCS 1–100 AU had chronic events. Subjects with
TCS 101–600 AU presented 10 (9%) chronic and 5
(4.5%) acute events (p < 0.001).S - Total calcium score (AU).
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The main finding of our study is that asymptomatic sub-
jects with ECAC, both with and without DM did not de-
veloped first acute CAD-related events during up to
10 years of follow-up. Our data support the suggestion
that ECAC is associated with a stable form of athero-
sclerosis which is mainly manifested by a chronic rather
than acute course of CAD [7-9].
Previous studies have shown a dramatically increased
incidence rate of CAD events (when all types of events
pooled together) among those with the highest levels of
CAC compared to those with CAC = zero [3-6]. However,
as we demonstrate in the current analysis, a different pat-
tern in development of acute and chronic coronary events
in accordance with CAC category can be distinguished.
The acute events in our study occurred mostly in subjects
with mild and moderate CAC and even in absence of
CAC. This might have an important clinical relevance,
since minimal or mild CAC should not be categorized into
a lower risk category (as suggested by the SHAPE inves-
tigators) [17]. These findings are also supported by his-
topathological studies, intravascular ultrasound and CT
observations that consistently demonstrated that acute
events rise mainly from soft non-calcified or mildly calci-
fied plaques [18-27]. In a series of cases of sudden coron-
ary death, more than 50% of thin-cap fibroatheromas
showed a lack of calcification or only speckled calcification
on postmortem radiographs of coronary arteries [18]. Sev-
eral studies demonstrated the destabilizing effect of the
lipid core, whereas presence of calcium was a stabilizing
force and calcified lesions were more resistant to rupture
(similar to fibrous plaque) [19,20].
Thus, it seems that ECAC represents a long standing
chronic stage of slowly growing coronary atherosclerosis
and can be regarded as a healing process leading to sta-
bilization and decrease vulnerability of the plaques [28].
On the other hand, ECAC causes negative vessels re-
modeling resulting in flow restriction and leading to
clinical manifestations such as chronic angina or silent
ischemia upon a routine stress test [18-28].
The prevalence of CAC in our patients with DM was
significantly higher than in patients without DM. The
clinical value of CAC score in diabetic patients has been
recently demonstrated in several studies: CAC score can
further stratify diabetic patients according to the pres-
ence and extent of CAC into patients with very low or
high CV risk [10-13,29].
It should be stated that our population was predomin-
antly masculine, and this may represent a potential limi-
tation since the epicardial adipose tissue volume shows
gender disparities, being strongly associated with coron-
ary atherosclerosis in men [30]. Therefore, despite of the
strong theoretical background and biological plausibility,
caution should be used in interpreting our findingsbecause it was not a randomized controlled trial and we
cannot rule out other factors that could have influenced
the observed clinical outcomes.
Conclusions
Asymptomatic subjects with ECAC did not develop first
acute events, but presented a high level of chronic CAD-
related events during a long term follow-up. In contrast,
most of the acute CAD-related events firstly occurred in
subjects with mild and moderate CAC.
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